topper's finally got some new material, page-57

re: sirtex medical adding more centers The company has added 11 US centers since ther last report, 36 US centers since the last year, and 2 centers in the last week. With revenues up 130% last quarter compared to a year ago, and the company training more oncolologists, and the Sir Spheres having new growth due to combined use of Sir Spheres from Sirtex and Irinotecan and Oxailplatin from Pfizer and Sanofi and new offlabel use for more types of cancer, that have metastasized to the liver, the growth is really starting to rev upwards. Either way through big eanings growth or through a buyout by a larger pharma , the company is dirt cheap at $2 compared to a few years ago when Cephalon did their due diligence and offered $4.85 for the co which was subsequently rejected. I dont care what you think you are entitled to your opinion and I am to mine . Do your own homework man.